Omeprazol Medical Valley (Omeprazole)

• Omeprazole is a proton pump inhibitor used to treat acid‑related gastrointestinal disorders.
• Gastro‑esophageal reflux disease (GERD): reduces symptoms and promotes healing of esophageal irritation.
• Peptic ulcer disease: facilitates ulcer healing by decreasing gastric acidity.
• NSAID‑induced ulcer prophylaxis: prevents ulcer formation in patients receiving non‑steroidal anti‑inflammatory drugs.
• Helicobacter pylori eradication (in combination therapy): enhances eradication rates when used with antibiotics and a bismuth compound.

• Omeprazole irreversibly binds to the H+/K+ ATPase enzyme (gastric proton pump) located on the secretory surface of parietal cells in the stomach. By inhibiting this final step of acid secretion, it markedly reduces the production of gastric hydrochloric acid, leading to an increase in gastric pH and allowing damaged mucosa to heal. The inhibition is sustained for up to 72 hours, allowing once‑daily dosing in most treatment regimens.

Omeprazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Headache: mild to moderate headache reported.
• Diarrhea: loose stools or increased bowel movements.
• Nausea: feeling of sickness or upset stomach.
• Abdominal pain: discomfort or cramps in the stomach area.
• Flatulence: increased gas production.
• Constipation: reduced bowel movements.

Serious or Rare Side Effects

• Clostridioides difficile infection: severe colitis due to bacterial overgrowth.
• Acute interstitial nephritis: kidney inflammation presenting with rash and fever.
• Stevens‑Johnson syndrome: rare severe skin reaction with blistering.
• Bone fracture: increased risk of hip or wrist fractures with long‑term use.

When prescribing omeprazole, several precautions should be considered to ensure safe use.

• Assess renal function: dose adjustment may be needed in severe renal impairment.
• Evaluate for CYP2C19 polymorphisms: altered metabolism can affect drug levels.
• Monitor for magnesium deficiency: long‑term therapy may cause hypomagnesemia.
• Use with caution in elderly: increased risk of fractures and infections.
• Avoid abrupt discontinuation: may cause rebound acid hypersecretion; taper if possible.
• Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Omeprazole can affect the pharmacokinetics of several medicines, leading to clinically relevant interactions.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk.
• Atazanavir: decreased absorption, loss of antiviral efficacy.
• Dasatinib: lowered plasma concentrations, reduced therapeutic effect.

Moderate Interactions (Monitor Closely)

• Warfarin: possible increase in INR, monitor coagulation.
• Phenytoin: increased serum levels, watch for toxicity.
• Methotrexate (high dose): elevated levels, monitor renal function.
• Digoxin: modest increase in concentration, assess for toxicity.